Schizotypy in Parkinson’s disease predicts dopamine-associated psychosis

Schizotypy in Parkinson’s disease predicts dopamine-associated psychosis

Abstract Psychosis is the most common neuropsychiatric side-effect of dopaminergic therapy in Parkinson’s disease (PD). It is still unknown which factors determine individual proneness to psychotic symptoms. Schizotypy is a multifaceted personality trait related to psychosis-proneness and dopaminerg...

Full description

Bibliographic Details
Main Authors:	Carina R. Oehrn, Jana Schönenkorb, Lars Timmermann, Igor Nenadić, Immo Weber, Phillip Grant
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-01-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-020-80765-5

Similar Items

An Overview of the Association between Schizotypy and Dopamine
by: Christine eMohr, et al.
Published: (2014-12-01)

Positive schizotypy : a proposed endophenotype for psychosis in neurological disorders
by: Bruen, Peita Danielle
Published: (2010)

Psychosis and Schizophrenia-Spectrum Personality Disorders Require Early Detection on Different Symptom Dimensions
by: Frauke Schultze-Lutter, et al.
Published: (2019-07-01)

Increased prefrontal top-down control in older adults predicts motor performance and age-group association
by: Philipp Alexander Loehrer, et al.
Published: (2021-10-01)

Stress, dopamine and vulnerability : a functional neuroimaging investigation of stress in schizotypy
by: Soliman, Alexandra
Published: (2007)

Parkinson’s disease psychosis
by: Jakel RJ, et al.
Published: (2014-03-01)

Parkinson Disease Psychosis: Update
by: J. H. Friedman
Published: (2013-01-01)

Investigating the relationship between the failures of inhibitory processes in psychosis and schizotypy : experimental and functional neuroimaging studies
by: Haworth, Elke Johanna
Published: (2003)

Impaired Facial Emotion Recognition in Individuals at Ultra-High Risk for Psychosis and Associations With Schizotypy and Paranoia Level
by: Eunchong Seo, et al.
Published: (2020-06-01)

Quetiapine in the treatment of psychosis in Parkinson’s disease
by: Paul Shotbolt, et al.
Published: (2010-11-01)

Approach to the management of psychosis in Parkinson’s disease
by: Abhishek Lenka, et al.
Published: (2019-01-01)

Psychosis in Parkinson′s disease
Published: (2011-01-01)

Electrophysiological resting state networks of predominantly akinetic-rigid Parkinson patients: Effects of dopamine therapy
by: Lukas Schneider, et al.
Published: (2020-01-01)

Characterization of information processing in the subthalamic area of Parkinson’s patients
by: Immo Weber, et al.
Published: (2020-04-01)

Is schizotypy per se a suitable endophenotype of schizophrenia? - Do not forget to distinguish positive from negative facets
by: Phillip eGrant
Published: (2015-10-01)

Cortical and Striatal Reward Processing in Parkinson’s Disease Psychosis
by: Graham K. Murray, et al.
Published: (2017-04-01)

The role of mirtazapine in the management of psychosis in Parkinson’s disease
by: N Uvais
Published: (2020-01-01)

Psychosis, apathy, depression and anxiety in Parkinson's disease
by: David A. Gallagher, et al.
Published: (2012-06-01)

Intermittent degradation and schizotypy
by: Matthew W. Roché, et al.
Published: (2015-06-01)

Emotion Recognition in Schizotypy
by: Brown, Laura
Published: (2010)

Schizotypy and preconscious processing
by: Evans, Julie Louise
Published: (1992)

Cognitive differences and schizotypy
by: Beech, Anthony R.
Published: (1987)

Schizotypy and contextual integration
by: Saunders, A.
Published: (2008)

The impact of schizotypy on pragmatics
by: Monica de Freitas Frias Chaves, et al.
Published: (2020-10-01)

Positive schizotypy and negative schizotypy are associated with differential patterns of episodic memory impairment
by: Lili Sahakyan, et al.
Published: (2016-09-01)

Dopamine dysregulation syndrome in Parkinson’s disease
by: A V Nikitina, et al.
Published: (2013-03-01)

Nonclinical psychotic-like experiences and schizotypy dimensions: Associations with hippocampal subfield and amygdala volumes
by: Evermann, U., et al.
Published: (2021)

Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice
by: Khashayar Dashtipour, et al.
Published: (2021-01-01)

The experience of care partners of patients with Parkinson's disease psychosis.
by: Sneha Mantri, et al.
Published: (2021-01-01)

Evidence for the use of pimavanserin in the treatment of Parkinson’s disease psychosis
by: Harini Sarva, et al.
Published: (2016-11-01)

A clinical profile of patients with Parkinson′s disease and psychosis
by: B. R. Amar, et al.
Published: (2014-01-01)

Psychosis in an elderly patient with parkinson′s disease: issues and considerations
by: Arghya Pal, et al.
Published: (2014-01-01)

High Schizotypy Predicts Emotion Recognition Independently of Negative Affect
by: Christopher Dawes, et al.
Published: (2021-09-01)

Ventral striatal dopamine synthesis capacity predicts financial extravagance in Parkinson’s Disease
by: Andrew David Lawrence, et al.
Published: (2013-02-01)

Psychosis in parkinsonism: an unorthodox approach
by: Onofrj M, et al.
Published: (2017-05-01)

Reizkompetition und positive Schizotypie
by: Wolff, Monika
Published: (2004)

Theory of Mind Impairment and Schizotypy
by: Meyer, Joseph Francis
Published: (2005)

Suggestibility, Dissociation and Positive Schizotypy
by: Emma Barkus, et al.
Published: (2010-01-01)

Schizotypy and out-of-the-body experiences
by: McCreery, Charles
Published: (1993)

Schizotypy and emotional memory enhancement
by: Hoshi, R.
Published: (2010)